Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes

Journal of Virology

Volumn 77, Issue 4, 2003, Pages 2469-2476

  Kasahara, Senji ^a   Ando, Kazuki ^a   Saito, Kuniaki ^a   Sekikawa, Kenji ^c   Ito, Hiroyasu ^a   Ishikawa, Tetsuya ^d   Ohnishi, Hiroo ^b   Seishima, Mitsuru ^a   Kakumu, Shinichi ^d   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^d AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ASSAY; CELL CLONE; CELL LINE; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DILUTION; GENETIC CODE; HEPATITIS B VIRUS; IMMUNIZATION; IN VITRO STUDY; KNOCKOUT MOUSE; MOUSE STRAIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TIME; WILD TYPE;

ANIMALS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037320085     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.4.2469-2476.2003     Document Type: Article

References (48)

1. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158:5283-5291.
2. Ando, K., L. G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245-3253.
3. Ando, K., T. Moriyama, L. G. Guidotti, S. Wirth, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1993. Mechanisms of class I-restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1541-1554.
4. Banchereau, J., F. Biere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Paluckae. 2000. Immunology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
5. Banchereau, J., and R. M. Steinman. 1998. Myeloid dendritic cells and the control of immunity. Nature 392:245-252.
6. Baxter, G. T., R. C. Kuo, O. J. Jupp, P. Vandenabeele, and D. J. MacEwan. 1999. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J. Biol. Chem. 274:9539-9547.
7. Beyer, H. S., and M. Stanley. 1990. Tumor necrosis factor-alpha increases hepatic DNA and RNA and hepatocyte mitosis. Biochem. Int. 22:405-410.
8. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. J. Immunol. 146:4301-4307.
9. Braun, M. Y., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft- versus-host disease. J. Exp. Med. 183:657-661.
10. Chisari, F. V. 1997. Cytotoxic T cells and viral hepatitis. J. Clin. Investig. 99:1472-1477.
11. Crowe, P. D., B. N. Walter, K. M. Mohler, C. Otten-Evans, R. A. Black, and C. F. Ware. 1995. A metalloproteinase inhibitor blocks shedding of 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1205-1210.
12. Davis, H. L., B. A. Demeneix, B. Quantin, J. Coulombe, and R. G. Whalen. 1993. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4:733-740.
13. Davis, H. L., M. L. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847-1851.
14. + T cells. J. Exp. Med. 174:875-880.
15. Elkon, K. B., C. C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. A. Abrahamsen, X. Song, J. L. Zhou, L. J. Old, R. G. Crystal, and E. Falck-Pedersen. 1997. Tumor necrosis factor a plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 94:9814-9819.
16. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owens, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. 1994. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature 370:555-557.
17. Gilles, P. N., G. Fey, and F. V. Chisari. 1992. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955-3960.
18. + T lymphocytes. Cytokines Mol. Ther. 1:211-221.
19. Guidotti, L. G., and F. V. Chisari. 1999. Cytokine-induced viral purging-role in pathogenesis. Curr. Opin. Microbiol. 2:388-391.
20. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curt. Opin. Immunol. 8:478-483.
21. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91:3764-3768.
22. Guidotti, L. G., S. Guilhot, and F. V. Chisari. 1994. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J. Virol. 68:1265-1270.
23. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
24. Hill, G. R., T. Teshima, V. I. Rebel, O. I. Krijanovski, K. R. Cooke, Y. S. Brinson, and J. L. M. Ferrara. 2000. The p55 TNF-α receptor plays a critical role in T cell alloreactivity. J. Immunol. 164:656-663.
25. Hobbs, M. V., W. O. Weigle, D. J. Noonan, B. E. Toebett, R. J. McEvilly, R. J. Koch, G. J. Cardenas, and D. N. Erst. 1993. Patterns of cytokine gene expression by CD4 cells from young and old mice. J. Immunol. 150:3602-3614.
26. + T cells. J. Immunol. 149:1319-1325.
27. + T cells by TNF-alpha. Lymphokine Cytokine Res. 10:307-315.
28. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
29. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Nomura, H. Miura, I. Nakamura, Y. Yazaki, and M. Imawari. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039-1044.
30. Kohchi, C., Y. Tanabe, K. Noguchi, D. Mizuno, and G. Soma. 1996. Induction of differentiation in embryonic stem cells by 26-kD membrane-bound tumor necrosis factor (TNF) and 17-kD free TNF. In Vivo 10:19-27.
31. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagi, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, Y. Shinkai, F. W. Alt, A. Matsuzawa, S. Yonehara, and H. Takayama. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357-364.
32. Koziel, M. J., D. Dudley, N. Afdhal, A. Grakoui, C. M. Rice, Q. L. Choo, M. Houghton, and B. D. Walker. 1995. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin Investig. 96:2311-2321.
33. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. Wong, E. Y. Chen, and D. V. Goeddel. 1991. Cloning and expression of cDNA for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830-2834.
34. + monocytes through distinct pathways that active NF-KB. J. Immunol. 165:3647-3655.
35. Marino, W. M., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
36. Matsumoto, M., Y. X. Fu, H. Molina, and D. D. Chaplin. 1997. Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137-144.
37. Michalopoulos, G. K., and M. C. DeFrances. 1997. Liver regeneration. Science 276:60-66.
38. Nakamoto, Y., L. G. Guidotti, V. Pasquetto, R. D. Schreiber, and F. V. Chisari. 1997. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158:5692-5697.
39. Roake, J. A., A. S. Rao, P. J. Moris, C. A. Larsen, D. F. Hankins, and J. M. Austin. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
40. Schirmbeck, R., W. Bohm, K. Ando, F. V. Chisari, and J. Reimann. 1995. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69:5929-5934.
41. Selleri, C., T. Sato, S. Anderson, N. S. Young, and J. P. Maciejewski. 1995. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and programmed cell death. J. Cell. Physiol. 165:538-546.
42. Snoeck, H. W., S. Weekx, A. Moulijn, F. Lardon, M. Lenjou, G. Nys, P. C. Van Ranst, D. R. Van Bockstaele, and Z. N. Berneman. 1996. Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma. J. Exp. Med. 183:705-710.
43. + T cells. J. Immunol. 165:5537-5543.
44. Taniguchi, T., M. Tanaka, A. Ikeda, E. Momotani, and K. Sekikawa. 1997. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha deficient mice. Lab. Investig. 77:647-654.
45. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
46. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. F. Huang, J. D. E. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91:10854-10858.
47. Webber, E. M., J. Bruix, R. H. Pierce, and N. Fausto. 1998. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28:1226-1234.
48. Wong, G. H. W., and D. V. Goeddel. 1986. Tumor necrosis factor α and β inhibited virus replication and synergize with interferons. Nature 323:819-822.